Index
S&P 500
Market Cap
33.89B
Enterprise Value
-
Income
1.46B
Sales
203.90B
Book/sh
44.87
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
61100
IPO
Dec 13, 2001
P/E
23.46
Forward P/E
12.49
PEG
0.27
P/S
0.17
P/B
1.53
P/C
-
P/FCF
8.59
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
1.16
Debt/Eq
0.70
LT Debt/Eq
0.70
Option/Short
Yes / Yes
EPS (ttm)
2.92
EPS next Y
5.48
EPS next Q
-1.13
EPS this Y
149.95%
EPS next Y
5.43%
EPS next 5Y
46.89%
EPS past 3/5Y
- -
Sales past 3/5Y
10.45% 11.88%
EPS Y/Y TTM
127.37%
Sales Y/Y TTM
9.71%
EPS Q/Q
98.94%
Sales Q/Q
1.93%
Insider Own
1.78%
Insider Trans
-2.05%
Inst Own
100.23%
Inst Trans
1.87%
ROA
1.81%
ROE
6.77%
ROIC
3.88%
Gross Margin
-
Oper. Margin
0.78%
Profit Margin
0.72%
SMA20
0.55%
SMA50
3.54%
SMA200
23.66%
Trades
Shs Outstand
494.97M
Shs Float
486.26M
52W High
72.50 -5.59%
52W Low
31.63 116.41%
Volatility
5.55% 3.78%
ATR (14)
2.61
RSI (14)
53.35
Beta
1.10
Rel Volume
1.05
Avg Volume
4.56M
Volume
4,807,946
Perf Week
-2.45%
Perf Month
12.23%
Perf Quarter
7.36%
Perf Half Y
28.33%
Perf YTD
66.34%
Perf Year
95.46%
Perf 3Y
0.72%
Perf 5Y
-3.92%
Perf 10Y
116.82%
Prev Close
68.62
Price
68.45
Change %
-0.25%
Analysts 13 incl. previous ratings
Rating Distribution 5 Buy · 7 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 11, 2026 Upgrade A Argus
Hold → Buy $80 +16.9% Jun 23, 2026 Initiated R RBC Capital Mkts
Sector Perform $70 +2.3% May 20, 2026 Upgrade D Deutsche Bank
Hold → Buy $80 +16.9% Apr 29, 2026 Upgrade C Cantor Fitzgerald
Neutral → Overweight $60 -12.3% Apr 29, 2026 Upgrade B BofA Securities
Underperform → Buy $60 -12.3% Jan 05, 2026 Upgrade B Barclays
Equal Weight → Overweight $54 -21.1% Oct 14, 2025 Initiated G Goldman
Sell $33 -51.8% Jul 28, 2025 Downgrade C Cantor Fitzgerald
Overweight → Neutral $38 -44.5% Jul 23, 2025 Downgrade W Wells Fargo
Overweight → Equal Weight $30 -56.2% Jul 21, 2025 Downgrade T TD Cowen
Buy → Hold $33 -51.8% Jul 16, 2025 Downgrade B BofA Securities
Neutral → Underperform $30 -56.2% Jul 10, 2025 Downgrade M Morgan Stanley
Overweight → Equal-Weight $33 -51.8% Jul 02, 2025 Downgrade U UBS
Buy → Neutral $45 -34.3% Jul 02, 2025 Downgrade J JP Morgan
Overweight → Neutral $48 -29.9% Jun 09, 2025 Resumed M Morgan Stanley
Overweight $70 +2.3% Jun 02, 2025 Downgrade B Barclays
Overweight → Equal Weight $65 -5.0% Apr 08, 2025 Upgrade J Jefferies
Underperform → Hold $64 -6.5% Feb 06, 2025 Downgrade A Argus
Buy → Hold Dec 17, 2024 Resumed J JP Morgan
Overweight $80 → $75 +9.6% Dec 13, 2024 Upgrade U UBS
Neutral → Buy $79 → $80 +16.9%
Show Previous Ratings
Oct-29-26 03:58PM
Oct-28-26 08:53AM
Oct-27-26 12:32PM
10:37AM
07:00AM
06:55AM
Loading…
06:55AM
(The Wall Street Journal)
06:10AM
06:00AM
05:29AM
04:39AM
Oct-26-26 08:55AM
Oct-21-26 09:09AM
Oct-20-26 07:01AM
Oct-19-26 05:30PM
Oct-16-26 10:54AM
08:00AM
Loading…
08:00AM
Oct-15-26 09:14AM
Oct-13-26 05:10PM
07:00AM
Oct-12-26 09:41AM
Oct-09-26 09:13AM
Oct-07-26 07:00AM
Oct-03-26 12:03PM
Oct-02-26 01:30PM
01:26PM
Oct-01-26 07:00AM
Sep-29-26 02:25PM
Sep-23-26 05:06PM
12:26PM
Sep-22-26 02:09PM
01:29PM
Loading…
01:29PM
12:22PM
Sep-16-26 01:16PM
Sep-14-26 03:41PM
Sep-10-26 03:36PM
Sep-09-26 03:30PM
03:15PM
Sep-03-26 01:35PM
Sep-01-26 09:00AM
Aug-31-26 02:25PM
08:00AM
07:28AM
Aug-27-26 07:26PM
Aug-25-26 02:58PM
Aug-24-26 01:04PM
Aug-21-26 04:58PM
12:00PM
Aug-20-26 08:00AM
Aug-17-26 04:30PM
07:58AM
06:00AM
Aug-13-26 05:50PM
02:16PM
11:40AM
09:30AM
Aug-11-26 02:09PM
09:38AM
Aug-07-26 04:40PM
Aug-05-26 11:50AM
08:00AM
Jul-31-26 10:36AM
Jul-28-26 05:41PM
05:02PM
04:18PM
11:28AM
(Investor's Business Daily)
08:19AM
08:15AM
06:48AM
(The Wall Street Journal)
06:08AM
06:00AM
06:00AM
Jul-24-26 04:56PM
Jul-21-26 05:26PM
04:33PM
Jul-20-26 10:43AM
Jul-17-26 06:02PM
04:30PM
Jul-16-26 09:19AM
08:58AM
08:30AM
Jul-15-26 07:21AM
Jul-13-26 03:00AM
Jul-10-26 08:45AM
07:55AM
Jul-09-26 09:47AM
07:00AM
Jul-08-26 05:32AM
Jul-03-26 08:20AM
Jul-01-26 08:02PM
04:30PM
Jun-24-26 07:51AM
Jun-23-26 01:35PM
Jun-22-26 04:30PM
Jun-18-26 02:48PM
Jun-17-26 05:30AM
(The Wall Street Journal)
Jun-16-26 11:47AM
11:44AM
09:30AM
08:00AM
05:34AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KOSTER CHRISTOPHER Secretary & General Counsel Aug 26 '26 Sale 66.90 56,500 3,779,850 248,854 Aug 27 04:45 PM Burdick Kenneth A Former Director Aug 26 '26 Proposed Sale 65.00 43,600 2,834,000 Aug 26 04:26 PM KOSTER CHRISTOPHER Officer Aug 26 '26 Proposed Sale 66.90 56,500 3,779,852 Aug 26 01:45 PM KOSTER CHRISTOPHER Secretary & General Counsel Aug 18 '26 Sale 65.36 47,603 3,111,332 305,354 Aug 19 04:45 PM KOSTER CHRISTOPHER Officer Aug 18 '26 Proposed Sale 65.36 47,603 3,111,262 Aug 18 03:32 PM Burdick Kenneth A Former Director Aug 05 '26 Proposed Sale 68.15 100,000 6,815,182 Aug 05 04:21 PM Burdick Kenneth A Director Jun 10 '26 Sale 64.55 80,000 5,164,000 197,086 Jun 11 05:22 PM Burdick Kenneth A Director Jun 10 '26 Proposed Sale 64.55 80,000 5,164,227 Jun 10 04:43 PM Burdick Kenneth A Director Dec 03 '25 Sale 39.04 33,211 1,296,557 305,161 Dec 05 05:06 PM Burdick Kenneth A Director Dec 04 '25 Sale 39.00 32,796 1,279,044 272,365 Dec 05 05:06 PM Burdick Kenneth A Director Dec 04 '25 Proposed Sale 39.00 32,796 1,279,044 Dec 04 04:39 PM Burdick Kenneth A Director Dec 03 '25 Proposed Sale 39.04 33,211 1,296,621 Dec 03 04:59 PM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
CEO & Director Ms. Sarah M. London
Executive VP & CFO Mr. Andrew Lynn Asher
Chief Operating Officer Ms. Susan R. Smith
Executive VP Mr. Christopher Andrew Koster
Senior VP & Chief People Officer Ms. Tanya M. McNally